This comes down to a procedure called contralateral prophylactic mastectomy, removing the unaffected breast alongside the one being treated for cancer, and whether it makes sense for you depends heavily on genetic risk, family history, and honestly, your own peace of mind. There’s no single right answer here. Some women with average risk decide against it entirely. Some with elevated genetic risk decide it’s worth the extra surgery. Both can be reasonable decisions depending on the full picture.
Dr. Sandeep Nayak, known for the Best Cancer Treatment in Bangalore, sees this question come up almost every time a new breast cancer diagnosis is discussed. “Women often ask this in the same breath as asking about their main treatment plan, understandably, they want to remove every possible risk at once. But this isn’t a decision that should be rushed alongside the urgency of treating the actual cancer. It deserves its own conversation, ideally with genetic testing results in hand.”
Weighing this decision for your own diagnosis?
What Actually Factors Into This Decision?
The reasoning behind this choice varies a lot depending on individual risk, not personal anxiety alone:
- A confirmed BRCA1 or BRCA2 mutation, or another known hereditary risk gene, meaningfully raises the odds of a new cancer developing in the other breast, which is where genetic counselling becomes genuinely useful before deciding
- A strong family history of breast cancer, even without a confirmed genetic mutation, can still factor into the decision, though the risk calculation looks different than it does for confirmed carriers
- Without a known genetic or strong family risk factor, the statistical chance of cancer developing in the healthy breast is fairly low, which changes the risk-benefit calculation considerably
- Personal peace of mind is a legitimate factor here, not just a secondary consideration, ongoing anxiety about the other breast is a real quality of life issue for many women, even when the statistical risk is modest
None of these factors point to one universal answer. They’re inputs into a decision that looks different for every patient depending on which of them actually applies.
What This Decision Actually Involves Beyond the Surgery Itself?
Choosing this path affects more than just the operating room, it shapes recovery and reconstruction planning too:
- Removing the healthy breast alongside the affected one usually means reconstruction planning has to account for both sides, not just the one being treated for cancer
- Surgery becomes more extensive with two breasts involved instead of one, which means a longer initial recovery than treating just the affected side
- This doesn’t reduce the risk of the original cancer coming back, contralateral prophylactic mastectomy addresses future risk in the other breast specifically, not recurrence of the existing diagnosis
- The decision doesn’t need to be made immediately, there’s usually room to complete genetic testing and think it through without rushing into it during the acute treatment phase
The emotional pull to “just remove everything” is completely understandable, but it’s worth separating that instinct from what the actual risk numbers say for your specific situation.
Why Choose MACS Clinic for This Decision?
Dr. Sandeep Nayak’s team walks through genetic testing results and actual risk numbers before this conversation happens, rather than treating it as an automatic add-on to the main surgery, so the decision reflects a patient’s real risk profile and priorities rather than fear alone. Reconstruction planning gets discussed alongside this decision too, since it changes how both sides are approached surgically, not something worked out afterward as an afterthought. The goal is a decision the patient actually feels settled about a year later, not one made quickly in the middle of an already overwhelming diagnosis.
FAQs
Does removing the healthy breast improve my odds of surviving the current cancer?
No, it doesn’t affect the prognosis of the cancer already diagnosed. It addresses the separate risk of a new cancer developing in the other breast.
Do I need a BRCA mutation to be considered for this procedure?
Not necessarily, though it’s the clearest risk factor. Strong family history alone is sometimes considered too, depending on the overall picture.
Will this decision delay my main cancer treatment?
It shouldn’t need to. Genetic testing can often be completed within the normal treatment planning window without pushing back the primary surgery.
Is anxiety about the other breast a valid reason on its own?
It’s a legitimate factor to discuss, yes, though it’s worth weighing alongside your actual risk numbers rather than deciding on anxiety alone.
References
NCI: Surgery to Reduce the Risk of Breast Cancer
ASBrS Consensus Statement – CPM
Disclaimer:This content is published for educational and informational purposes only.